Status:
COMPLETED
Familial Hypocalciuric Hypercalcemia: Clinical Aspects and Evolution
Lead Sponsor:
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Collaborating Sponsors:
Hospital Clinic of Barcelona
Conditions:
Familial Hypocalciuric Hypercalcemia
Eligibility:
All Genders
Brief Summary
Familial hypocalciuric hypercalcemia (FHH) is a rare disease (ORPHA#405, www.orpha.net) and most likely underdiagnosed, that clinicians should be aware of in the differential diagnosis of a hypercalce...
Eligibility Criteria
Inclusion
- Patients with clinical and biochemical suspicion of FHH who, at the discretion of the physician in routine clinical practice, were asked to perform a genetic evaluation of FHH and whose genetic results are available.
Exclusion
- Genetic study of FHH is not available or was not performed despite clinical and biochemical suspicion of FHH.
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2023
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04872894
Start Date
February 1 2021
End Date
April 1 2023
Last Update
April 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain, 08041